The US Department of Health and Human Services (HHS)—through the Centers for Medicare and Medicaid Services (CMS)—has announced that some Medicare enrollees will pay less for 64 drugs available through Medicare Part B. 27 June 2024
Following on from warnings made by national regulators and Novo Nordisk, the World Health Organization (WHO) has become the latest to warn about falsified semag 21 June 2024
Deal volume was up 20% in the pharmaceutical and life sciences sector in the last 12 months as dealmakers grew more comfortable with uncertainty, according to a 21 June 2024
Johnson & Johnson has submitted for an additional approval for Tremfya (guselkumab) to treat adults with moderately to severely active Crohn's disease. 21 June 2024
In the USA, the Food and Drug Administration has announced the availability of a draft guidance for industry which could smooth the path for biosimilars develop 21 June 2024
French vaccines major Sanofi and Biovac, a Cape Town-based biopharmaceutical company, have announced a partnership to produce inactivated polio vaccines in Afri 20 June 2024
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.